OBJECTIVE:
To compare the clinical efficacy on chronic ulcerative colitis between electroacupuncture (EA) combined with acupoint sticking therapy (AST) and western medicine.
Dr. Tony Willcox at in BoZhou, China treating patients for digestive discomfort.
METHODS:
Ninety cases were randomly divided into EA + AST group and western medication group, 45 cases in each one. In EA + AST group, (1) Zhongwan (CV 12), Tianshu (ST 25), Guanyuan (CV 4), Qihai (CV 6) and (2) Shangjuxu (ST 37), Pishu (BL 20), Dachangshu (BL 25), Zusanli (ST 36) were selected for EA and AST by turns. In the western medication group, Mesalazine was administered orally. Clinical symptom evaluation and colonoscopic examination were conducted respectively before and after treatment, and the differences in efficacy were compared.
RESULTS:
In EA + AST group, the total effective rate of clinical symptoms was 91.1% (41/45) and the total effective rate of the colonoscopic improvements in mucosal lesions was 84.4% (38/45), which were all superior to those (73.3%, 33/45; 66.7%, 30/45) in medication group (both P
CONCLUSION:
Acupuncture for ulcerative colitis, the combination of electroacupuncture and acupoint sticking therapy can improve in clinical symptoms and colonoscopic mucosal lesions significantly in patients with ulcerative colitis and the efficacy of it is superior to that of Mesalazine.
Resources
1- By Acupuncture-Moxibustion Department, Xiangcheng Municipal Hospital of TCM, Xiangcheng 466200, Henan Province, China. All rights reserved.
– http://www.ncbi.nlm.nih.gov/pubmed/20886789
Dr. Tony Willcox has spent many clinic hours in Yueyang and Shuguang the hospitals in Shanghai and Anhui University of Chinese Medicine in Hefei China as well as Jinxiang Hospital Anhui Province and Bozhou Hospital in Anhui Province. Much clinical experience is gained from treating patients in China. Many diseases and conditions are present due to the enormous population that is reliant on traditional Chinese medicine and the benefits of Acupuncture to restore and improve patients’ health and wellness.